#ASOWebinar: Obesity and Respiratory disease
Novo Nordisk has provided sponsorship to the Association for the Study of Obesity (ASO) to fully fund all costs for the development of this webinar, including creation, organisation, production and administration. Novo Nordisk has had no influence on the content and full editorial control remains the sole responsibility of ASO. None of the speakers have received a fee for their participation in this webinar, and ASO has been fully responsible for engaging with participants.
When: Thursday, 17th November 2022, 6:00pm - 7:30pm
This is a Novo Nordisk sponsored webinar
This webinar will consider and understand the burden, pathophysiology, assessment and treatment of respiratory disease in people living with obesity. Following the talks from invited speakers, there will be a panel discussion with a Q&A session facilitated by the Chair, that will allow webinar attendees to ask the panel questions.
The webinar is a continuation of the highly successful ASO webinar series that started shortly after the initial outbreak of covid-19 and is designed to support the ASO membership and others interested in obesity and weight management.
1800-1810 Welcome and Introductions - Dr Georgios Dimitriadis (Consultant Endocrinologist, Kings College London and ASO Trustee)
1810-1825 Obesity Hypoventilation - Dr Patrick Murphy
1825-1840 Exercise in chronic lung disease - Dr Thomas Ward
1840-1855 Pre-operative respiratory assessment - Dr Branavan Retnasingham
1855-1930 Panel discussion and question and answer session (Drs Murphy, Ward, Retnasingham and Sadeghimakki, Chaired by Dr Dimitriadis)
Please join us for the live panel discussion and Q & A session
Speakers
Dr Georgios Dimitriadis
Consultant Endocrinologist and Lead Bariatric Physician, King's College Hospital NHS Foundation Trust
Dr Roham Sadeghimakki
Physician and obesity researcher with a special interest in body composition, respiratory function, and cardiometabolic health,
